Alkem Laboratories Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Alkem Laboratories Ltd. on BSE

Search Inside the pdf :

Alkem Laboratories Ltd.

27 May 2025, 02:59PM

5245.00

-0.40%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Please find enclosed herewith the details of investor meeting scheduled to be held on 03rd June, 2025

pdf

Alkem Laboratories Ltd.

19 May 2025

5245.00

-0.40%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss the Q4FY25 and FY25 financial results will be held on Thursday, 29th May, 2025 at 04.30 p.m. Please find attached herewith the conference call details.

pdf

Alkem Laboratories Ltd.

16 May 2025

5245.00

-0.40%

Board Meeting

Alkem Laboratories Ltd - 539523 - Board Meeting Intimation for Notice Of Meeting Of Board Of …

BSE India

Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 ,inter alia, to consider and approve (i) the Standalone and Consolidated Audited Financial Results of the Company for the quarter and financial year ended 31st March, 2025; and (ii) to consider and recommend Final Dividend, if any, for financial year ended 31st March, 2025. Kindly take note of the same.

pdf

Alkem Laboratories Ltd.

15 May 2025

5245.00

-0.40%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement Under Regulation 30 (LODR) With Respect To A Cyber …

BSE India

Enclosed herewith is the disclosure with respect to a cyber security incident involving a US subsidiary of Enzene Biosciences Limited, a subsidiary of the Company.

pdf

Alkem Laboratories Ltd.

23 Apr 2025

5245.00

-0.40%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Updates on Acquisition

BSE India

In continuation of our earlier intimations dated 07th February, 2025 and 28th March, 2025, we wish to inform you that today i.e. 23rd April, 2025, the acquisition of Adroit by the Company stands completed in accordance with the conditions prescribed in the share purchase agreement dated 28th March, 2025 and accordingly, Adroit will now be a wholly owned subsidiary of the Company. Kindly take the same on record.

pdf

Alkem Laboratories Ltd.

16 Apr 2025

5245.00

-0.40%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Updates on Acquisition

BSE India

In continuation of our earlier intimations dated 07th February, 2025 and 15th March, 2025, we wish to inform you that today i.e. 16th April, 2025, the acquisition of Bombay Ortho by Alkem Medtech stands completed in accordance with the conditions prescribed in the share purchase and share subscription agreement dated 15th March, 2025 and accordingly, Bombay Ortho will now be a wholly owned step-down subsidiary of the Company. Kindly take the same on record.

pdf

Alkem Laboratories Ltd.

31 Mar 2025

5245.00

-0.40%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

This is to inform you that Mr. Adil Billimoria, Senior Management Personnel of the Company shall retire from the Company with effect from closing of business hours of 31st March, 2025.

pdf

Alkem Laboratories Ltd.

28 Mar 2025

5245.00

-0.40%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement Under Regulation 30 Of SEBI LODR- Regulatory Order

BSE India

Pursuant to Regulation 30 of SEBI LODR Regulations, 2015, this is to inform you that the Company has received orders passed by the statutory authority under the Goods and Services Tax Act, 2017. The relevant disclosure is enclosed herewith.

pdf

Alkem Laboratories Ltd.

28 Mar 2025

5245.00

-0.40%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Updates on Acquisition

BSE India

In continuation of our earlier intimation dated 07th February, 2025, we wish to inform you that today i.e. 28th March, 2025, a share purchase agreement has been executed, inter alios, amongst the Company and Adroit.

pdf

Alkem Laboratories Ltd.

25 Mar 2025

5245.00

-0.40%

SAST

Alkem Laboratories Ltd - 539523 - Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Madhurima Singh

pdf

Is Alkem Laboratories Ltd. worth buying?

138 Votes:

Buy 78.99%

Sell 14.49%

Hold 6.52%

RESEARCH REPORTS

Sell SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf